Becton Dickinson acquires CRISI Medical Systems Becton Dickinson announced the acquisition of CRISI Medical Systems, a San Diego-based medical technology company dedicated to improving the safety and delivery of IV injectable medications. The acquisition furthers BD's position in helping address preventable medication errors and improve care delivery efficiencies. Financial details on the acquisition are not being disclosed at this time. BD expects the transaction will be immaterial and does not expect it to impact BD's previously communicated FY15 earnings guidance.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.